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more difficult, facilitates the procedures described and results
in better outcomes.
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Single or double lung transplantation for pulmonary
hypertension
To the Editor:
We read with interest the article on lung transplantation by
Gammie and associates. l They compared short- and long-
term outcomes after single (STL, n == 21) and double lung
transplantation (DLT, n == 37) for patients with pulmonary
hypertension, defined as mean pulmonary artery pressure
greater than 30 mm Hg. They concluded that SLT is the oper-
ation of choice for recipients with pulmonary hypertension.
We are perplexed by the conclusion, especially in light of
an earlier report from the same institution proposing the
opposite. In an article published in 1994, the authors2 com-
pared the outcomes of the patients with and without pul-
monary hypertension who underwent SLT. The survival for
the 19 patients with pulmonary hypertension was dismal after
SLT. They concluded that "despite a shortage of donor
organs, single-lung transplantation may be suboptimal thera-
py in patients with PH [pulmonary hypertension]."
Our review of these authors' data seems to indicate that the
cohort of patients with pulmonary hypertension who under-
went SLT comprises most of the experience in both reports
except for 2 additional patients in the 1998 article. Both arti-
cles have provided convmcing data supporting their conclu-
sions. Unfortunately, they contradict each other! It would be
important for the authors to discuss and clarify the dh,crepan-
cies between these 2 articles and to elaborate on their reason-
ing behind the change in treatment from bilateral SLT to SLT
for patients with pulmonary hypertension. Citing their 1994
article merely for the definition of pulmonary hypertension
without a full discussion cannot serve the transplant commu-
nity well, especially when there is a major change in recom-
mendation. We would welcome the authors' comments re-
garding these 2 articles.
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Reply to the Editor:
We hope to clarify the concerns expressed by Park and his
colleagues regarding articles published by our group on the
issue of smgle (SLT) versus double lung transplantation
(DLT) for pulmonary hypertension. The original article
reported an early experience with SLT for patients with pul-
monary hypertension: it comprised patients undergoing trans-
plantation from 1990 through late 1992 and included an
analysis of 10 SLTs for pulmonary vascular disease and 9 for
parenchymal disease with pulmonary hypertension as an
associated finding. 1 The former group had systemic pul-
monary artery pressures, whereas the latter had substantially
lower pulmonary artery pressures. Follow-up was less than
18 months. The more recent article included patients under-
going transplantation through 1996 (including 10 patients
from the earlier series) and focused on those with pulmonary
vascular disease.2 The mean pulmonary artery systolic pres-
sure of this cohort was 100 mm Hg. Thus we were able to
compare 37 DLTs and 21 SLTs for pulmonary vascular dis-
ease, with a mean follow-up in excess of 3 years. The survival
data are unequivocal, demonstrating identical survival in the
SLT and DLT groups. The improved results over time of SLT
for pulmonary hypertension likely reflect the growing matu-
rity of our program, inasmuch as we have gained experience
with donor selection and perioperative management. Our data
are stnkmgly similar to those of the St Louis program, which
reported a 3-year survival of 61 % among 34 consecutive
SLTs for pulmonary hypertension.3
The earlier paper concluded, "Further study comparing
single versus bilateral lung transplantation for pulmonary
hypertension is necessary." We believe that our most recent
experience, with nearly 6 times as many patients with pUl-
monary vascular disease, represents just that.
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